Clinical Trials · NCT07389941
Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation
- Phase
- Phase 4
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University of Luebeck
- Enrollment
- 240
- Start date
- Oct 2026
- Locations
- See registry
- Primary endpoint
- Freedom from atrial arrhythmia (AF/atrial flutter/atrial tachycardia >30 sec) at 12 months post-ablation (8-week-blanking period)